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NG5 1PB, U.K.Determining the effectiveness of interventions in osteoar-
thritis (OA) is often based on the measurement of change in
outcomes such as pain, disability and quality of life. In
calculating and interpreting change in outcomes, the
assumption is that any change (greater than the measure-
ment error for the instrument) represents a real change in
outcome (i.e. a real reduction in pain or disability or a real
increase in quality of life). In a clinical trial such change is
largely attributed to the efficacy of the intervention. The
fundamental principle underlying this assessment of
change is that an individual’s attitude towards a particular
construct and their way of calibrating it will remain stable.
For example, that a visual analogue pain score (VAS) of
63 mm obtained before treatment will mean the same as a
VAS pain score of 63 mm obtained after treatment. How-
ever, there is increasing evidence that many patient-
perceived outcomes are not stable over time but alter in
response to adaptation to illness or symptoms, coping
strategies, and changes in expectations resulting from
experience (of treatment, other illness and social or demo-
graphic factors such as age). Indeed, the ability to recali-
brate symptoms such as pain, or to change expectations
and definitions about what constitutes quality of life are
often viewed as desirable attributes in chronic disease,
representing successful coping or adaptation to changed
circumstances. Why do we recognize, and welcome, dyna-
mism in patient-centered outcomes in clinical practice but
ignore it when making assessments of treatment efficacy?
One explanation for this apparent discrepancy is that
clinical impressions of the patient’s well-being, standard-
ized measures of outcome based on sound psychometric
principles and statistical methods used to calculate change
in outcome have largely developed as discrete methods of
assessment with their own underlying principles, rules and
assumptions. Few observers have recognized the impor-
tance of their clinical observations about adaptation to the
measurement of outcome or the interpretation of statistical
analyses of change. There is, however, a growing interest
in highlighting and explaining these relationships and in
developing statistical methods for measuring change1–3
that have important applications to the assessment of
treatment efficacy in arthritis.503Response shift; an explanation for dynamism in
patient-centered outcomes
The dynamism in patient-centered outcomes represents
what is described as response shift. Response shift refers
to a change in the meaning of self-evaluation of a particular
outcome and can occur as the result of two factors1:
(1) A change in the patient’s internal standards of
measurement. In other words, a recalibration of their
scale for that outcome. For example, a VAS pain
score of 63 mm before treatment may equate to a
pain score of 88 mm after treatment because the
patient’s expectations of pain relief have altered.
(2) A redefinition of the outcome by the patient. For
example, the symptom described as pain becomes
something different or those factors constituting
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Response shift explains many of the apparently para-
doxical quality of life and disability scores observed in
several populations of patients. For example, patients with
severe disabilities have reported good or excellent quality
of life, despite experiencing significant problems perform-
ing daily tasks, being socially isolated and having limited
incomes4. Patients having hemodialysis and peritoneal
dialysis, who experience a range of serious health prob-
lems, were more likely to rate themselves as ‘very happy’
than the general population5 and patients with neoplasms
have rated their quality of life in the top quarter of the WHO
quality of life questionnaire (higher scores equate to a
better quality of life)6.
This ‘disability paradox’ can be explained by response
shift in that patients may have adapted to their level of
disease and recalibrated their quality of life and disability
scales or reconceptualized what constitutes quality of life
and disability. There is specific evidence for recalibration
response shift in functional disability in elderly people with
recent health problems7, in quality of life in kidney trans-
plantation8, and in pain scores in patients with rheumatoid
arthritis (RA) (AJ Carr, 2001, personal communication).
In the study of kidney transplant patients6 mean pre-
transplant quality of life scores were 5.23 on a 10-point
scale. Post-transplantation, these scores had risen to 7. At
5, 12 and 18 months post-transplant, patients were asked
to retrospectively rate their quality of life before their
transplant and gave it scores of 3.27, 3.14 and 3.05
respectively, all lower than the original pre-transplant score.
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had been recalibrated by the experience of significantly
improved health after transplantation.
RA patients were asked to undertake a similar exercise
in rating their pain on a 100 mm VAS before and after
treatment and to make retrospective baseline pain ratings
after treatment (Then-tests). Calculating changes in pain
following treatment using the two sets of baseline ratings
gives very different estimates of treatment effect.
Data from qualitative studies in RA also support the
existence of response shift in pain and function. Patients
describe recalibration of their assessments of pain and
function, influenced by disease activity and duration (AJ
Carr et al. 2002, personal communication).OUTCOME MEASURES
The rationale behind the use of individualized or
preference-based outcome measures such as the SEIQoL
(Schedule for the Evaluation of Individualized Quality of
Life)9, MACTAR10, Disease Repercussion Profile (DRP)11
or Extended Q-TWiST method12 to assess response shift is
that they enable the conceptualization of function or quality
of life to be assessed for each individual patient and can
evaluate changes in individual preference weights. They
can be used to assess both recalibration and reconceptu-
alization response shift. Some (MACTAR and DRP) are
relatively easy and straightforward to use but others (for
example, the interviewer-administered version of SEIQoL)
are labour-intensive and time consuming and using the
Q-TWiST method in this way requires complex statistical
techniques.METHODOLOGICAL TECHNIQUES
The most widely used method for assessing response
shift is the then-test. This involves asking patients to make
baseline and post treatment assessments and then to
make post-treatment, retrospective assessments of base-
line health status using the same outcome measure. Theseretrospective then-tests should be performed at the same
time as the conventional post-treatment assessments. The
assumption is that the then-tests will be based on the same
internal calibration and conceptualization of the outcome as
the conventional post-treatment assessment. Any differ-
ence between the conventional baseline measure and the
then-test is assumed to be due to response shift. Whilst
the simplicity of this method is attractive, it is limited by the
potential problem of recall bias; studies in pain suggest
that the memory for chronic conditions can be very
inaccurate13.STATISTICAL METHODS
There are a number of statistical methods that can be
used to evaluate response shift by analysing longitudinal
data for statistical trends. These include covariance or
factor analysis, and growth curve analysis. Whilst they can
be very useful when used in conjunction with one of the
other methods for assessing response bias, alone they are
limited by their inability to give direct estimates of the
magnitude of recalibration or reconceptualization and by
the fact that some (factor analysis) require very large
sample sizes. However, their advantage is that they allow
several hypotheses about response shift to be tested.
Growth curve analysis in particular is being increasingly
used to assess response shift in quality of life data.QUALITATIVE RESEARCH
Qualitative methods such as semi-structured interviews
or focus groups can be used to provide detailed explana-
tions of the nature and size of response shifts. This can be
done either in a direct manner, by asking patients to
describe what constitutes quality of life for them or what a
pain score of 25 mm and so on means, or indirectly by
asking patients to specify their personal goals at different
time points. The main disadvantages with these methods
are that they are time consuming and labour intensive to
perform and analyse. Nevertheless, they can be very useful
adjuncts to other methods.Summary
The measurement and interpretation of change in
patient-centered outcomes in OA is likely to be significantly
confounded by changes in the ways patients calibrate and
conceptualize pain, disability, quality of life and so on. This
is particularly the case in long-term intervention studies or
studies of the natural history of disease. The prevalence
and magnitude of response shift in patient-centered out-
comes in OA have not been determined but there is
evidence from other musculoskeletal and chronic diseases
that it occurs, even over relatively short time periods. There
are a number of methods that can be used to identify and
quantify response shift and inclusion of the most appropri-
ate of these should be considered in all trials of treatment
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